Добавить новость
ru24.net
News in English
Декабрь
2024
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
22
23
24
25
26
27
28
29
30
31

Новости за 18.12.2024

Disney cuts transgender storyline from upcoming Pixar show - Euronews

Top Stories (us) - Google News (com) 

  1. Disney cuts transgender storyline from upcoming Pixar show  Euronews
  2. ‘Win Or Lose’ Transgender Actress Speaks Out After Disney Cuts Her Storyline: “Very Disheartened”  Deadline
  3. Black Trans Actress Responds to Disney Axing Her Character's Transgender Storyline From Upcoming Pixar Series  The Root
  4. ‘Win or Lose:’ Disney cuts transgender storyline from new animated series | CNN Business  CNN
  5. Disney Cuts Trans Storyline From Pixar's 'Win or Lose' Series  Variety

Why Marcus Rashford joining Arsenal is perfect fit but £325k-a-week Man Utd ace must first choose between cash or career

TheSun.co.uk 

MARCUS Rashford is at a crossroads.

But now the England star has to make the biggest choice he has ever faced – does he care about cash, or about his career?

GettyMarcus Rashford has admitted he is ‘ready for a new challenge’[/caption] GettyRashford could be a good fit at Arsenal under Mikel Arteta[/caption]

Rashford’s shock admission that he is “ready for a new challenge” after some two decades under the Manchester United umbrella has altered the dynamic around his future. Читать дальше...



SDV Market Tracker: 2024 Analysis

Wardsauto.com 

Wards Intelligence’s SDV Market Tracker reveals that U.S. automakers currently dominate the global software-defined vehicle (SDV) market, with Tesla’s Model Y and Model 3 projected to be the top-selling SDVs in 2024. However, Chinese OEMs are on track to overtake and assume market leadership in the near future.

Merck Enters into Exclusive Global License Agreement with Hansoh Pharma for Investigational Oral GLP-1 Receptor Agonist - Merck

Top Stories (us) - Google News (ru) 

  1. Merck Enters into Exclusive Global License Agreement with Hansoh Pharma for Investigational Oral GLP-1 Receptor Agonist  Merck
  2. Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal  CNBC
  3. Live news: Merck strikes $2bn deal with Chinese biotech to develop oral weight-loss drug  Financial Times
  4. Merck in Pact for Chinese Obesity Drug in Nearly $2 Billion Deal  Bloomberg
  5. Merck & Co. boosts GLP-1 portfolio by paying $112M... Читать дальше...

Новости России
Москва

Концерты звезд и отдых в лучших уголках мира – весь год с ENERGY!



Спорт в России и мире

Новости спорта


Новости тенниса
Андрей Рублёв

Андрей Рублёв обыграл Ника Кирьоса и принёс своей команде победу в Мировой теннисной лиге






Продажи украшений для детей выросли более чем в два раза в 2024 году

Гостиницы в центре Москвы на праздники почти заполнены

Появились кадры с места взрыва в отделении банка на северо-западе Москвы

В Москве произошёл взрыв в отделении банка